Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.

Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; European Collaborative Study in EuroCoord.; Swiss Mother & Child HIV Cohort Study..

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. doi: 10.1097/QAI.0b013e3182a334e3.


Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe.

Bailey H, Townsend CL, Cortina-Borja M, Thorne C; European Collaborative Study in EuroCoord..

AIDS. 2013 Sep 10;27(14):2312-5. doi: 10.1097/QAD.0b013e32836378e4.


Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.

European Collaborative Study in EuroCoord., Bailey H, Townsend C, Cortina-Borja M, Thorne C.

Antivir Ther. 2011;16(6):895-903. doi: 10.3851/IMP1849.


Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA; European Collaborative Study.; National Study of HIV in Pregnancy Childhood..

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):326-33. doi: 10.1097/QAI.0b013e31821d34d0. Erratum in: J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):e117.


Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.

Barone R, Pauwels S, De Camps J, Krenning EP, Kvols LK, Smith MC, Bouterfa H, Devuyst O, Jamar F.

Nephrol Dial Transplant. 2004 Sep;19(9):2275-81. Epub 2004 Jul 13.


Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86.

Walrand S, Jamar F, Mathieu I, De Camps J, Lonneux M, Sibomana M, Labar D, Michel C, Pauwels S.

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):354-61. Epub 2002 Dec 17.


86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.

Jamar F, Barone R, Mathieu I, Walrand S, Labar D, Carlier P, de Camps J, Schran H, Chen T, Smith MC, Bouterfa H, Valkema R, Krenning EP, Kvols LK, Pauwels S.

Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):510-8. Epub 2003 Feb 12.


Supplemental Content

Loading ...
Support Center